🇺🇸 FDA
Patent

US 10154975

Solid solution compositions and use in chronic inflammation

granted A61KA61K31/12A61K31/121

Quick answer

US patent 10154975 (Solid solution compositions and use in chronic inflammation) held by Infirst Healthcare Limited expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/12, A61K31/121, A61K31/192, A61K31/196